320 related articles for article (PubMed ID: 26239085)
21. Cellular Antisense Activity of PNA-Oligo(bicycloguanidinium) Conjugates Forming Self-Assembled Nanoaggregates.
Valero J; Shiraishi T; de Mendoza J; Nielsen PE
Chembiochem; 2015 Jul; 16(11):1593-600. PubMed ID: 26010253
[TBL] [Abstract][Full Text] [Related]
22. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model.
Petersen AL; Binderup T; Jølck RI; Rasmussen P; Henriksen JR; Pfeifer AK; Kjær A; Andresen TL
J Control Release; 2012 Jun; 160(2):254-63. PubMed ID: 22245688
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
[TBL] [Abstract][Full Text] [Related]
26. A novel engineered anti-CD20 tracer enables early time PET imaging in a humanized transgenic mouse model of B-cell non-Hodgkins lymphoma.
Natarajan A; Hackel BJ; Gambhir SS
Clin Cancer Res; 2013 Dec; 19(24):6820-9. PubMed ID: 24097872
[TBL] [Abstract][Full Text] [Related]
27. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
28.
Hicks RJ; Jackson P; Kong G; Ware RE; Hofman MS; Pattison DA; Akhurst TA; Drummond E; Roselt P; Callahan J; Price R; Jeffery CM; Hong E; Noonan W; Herschtal A; Hicks LJ; Hedt A; Harris M; Paterson BM; Donnelly PS
J Nucl Med; 2019 Jun; 60(6):777-785. PubMed ID: 30442752
[TBL] [Abstract][Full Text] [Related]
29. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and
Altai M; Westerlund K; Velletta J; Mitran B; Honarvar H; Karlström AE
Nucl Med Biol; 2017 Nov; 54():1-9. PubMed ID: 28810153
[TBL] [Abstract][Full Text] [Related]
31. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
[TBL] [Abstract][Full Text] [Related]
32. Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles.
Ma X; Devi G; Qu Q; Toh DF; Chen G; Zhao Y
Bioconjug Chem; 2014 Aug; 25(8):1412-20. PubMed ID: 25055196
[TBL] [Abstract][Full Text] [Related]
33. 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis.
Kang CM; Koo HJ; Lee S; Lee KC; Oh YK; Choe YS
Nucl Med Biol; 2013 Nov; 40(8):1018-24. PubMed ID: 24035550
[TBL] [Abstract][Full Text] [Related]
34. Receptor-mediated internalization of chelator-PNA-peptide hybridization probes for radioimaging or magnetic resonance imaging of oncogene mRNAs in tumours.
Tian X; Chakrabarti A; Amirkhanov N; Aruva MR; Zhang K; Cardi CA; Lai S; Thakur ML; Wickstrom E
Biochem Soc Trans; 2007 Feb; 35(Pt 1):72-6. PubMed ID: 17233604
[TBL] [Abstract][Full Text] [Related]
35. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation.
Yim CB; Dijkgraaf I; Merkx R; Versluis C; Eek A; Mulder GE; Rijkers DT; Boerman OC; Liskamp RM
J Med Chem; 2010 May; 53(10):3944-53. PubMed ID: 20411957
[TBL] [Abstract][Full Text] [Related]
37.
Pyo A; Yun M; Kim HS; Kim TY; Lee JJ; Kim JY; Lee S; Kwon SY; Bom HS; Kim HS; Kim DY; Min JJ
J Nucl Med; 2018 Feb; 59(2):340-346. PubMed ID: 28916621
[TBL] [Abstract][Full Text] [Related]
38. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.
Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M
J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795
[TBL] [Abstract][Full Text] [Related]
39. Application and Evaluation of [
Jiang Y; Gai Y; Long Y; Liu Q; Liu C; Zhang Y; Lan X
Mol Imaging; 2020; 19():1536012120916124. PubMed ID: 32559121
[TBL] [Abstract][Full Text] [Related]
40. Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles.
Chakrabarti A; Zhang K; Aruva MR; Cardi CA; Opitz AW; Wagner NJ; Thakur ML; Wickstrom E
Cancer Biol Ther; 2007 Jun; 6(6):948-56. PubMed ID: 17611392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]